Fentanyl Global Market Report 2026

Fentanyl is a synthetic opioid that is highly potent and used for pain relief and anesthesia. It is prescribed by doctors to manage severe pain, particularly after surgery and in advanced-stage cancer. It is available in forms such as transdermal patches and lozenges.

The main types of fentanyl include fentanyl injections and fentanyl TTS (transdermal therapeutic system). Fentanyl injections deliver the opioid directly into the bloodstream and are primarily used to relieve severe pain during and after surgery. They are applied in various situations, including anesthesia, maintenance of anesthesia, general analgesia, postoperative pain management, and breakthrough cancer pain, and are used by hospitals, clinics, ambulatory surgical centers, and others.

Tariffs have affected the fentanyl market by increasing the cost of raw materials and active pharmaceutical ingredients, leading to higher production expenses and supply chain disruptions. Injectable and transdermal fentanyl segments, especially in North America and Europe, are the most impacted due to dependency on global API imports. While tariffs pose challenges in cost and availability, they also encourage local manufacturing and innovation in drug delivery systems, potentially strengthening domestic production capacities and ensuring long-term supply stability.

The fentanyl market research report is one of a series of new reports from The Business Research Company that provides fentanyl market statistics, including fentanyl industry global market size, regional shares, competitors with a fentanyl market share, detailed fentanyl market segments, market trends and opportunities, and any further data you may need to thrive in the fentanyl industry. This fentanyl market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fentanyl market size has grown strongly in recent years. It will grow from $17.15 billion in 2025 to $18.17 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rising prevalence of chronic and cancer pain, increased postoperative surgeries, growing geriatric population, high adoption of injectable opioids, expansion of hospital and clinical infrastructure.

The fentanyl market size is expected to see strong growth in the next few years. It will grow to $23.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to development of novel fentanyl formulations, integration of AI in pain management, rising demand for home-based palliative care, increasing focus on opioid safety and regulation, growth of ambulatory surgical centers. Major trends in the forecast period include personalized pain management, novel transdermal drug delivery systems, minimally invasive anesthesia techniques, opioid stewardship programs, advanced formulation development.

The rising prevalence of chronic diseases is expected to drive the growth of the fentanyl market in the coming years. A chronic disease is a medical condition that persists for an extended period, typically three months or more, and often continues throughout a person's life. Fentanyl is primarily used in chronic diseases to manage severe, persistent pain that other medications or interventions cannot effectively control. For instance, in October 2025, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023, an estimated 57,100 adults aged 25 and above experienced acute coronary events, averaging approximately 156 incidents per day. Therefore, the increasing prevalence of chronic diseases is propelling growth in the fentanyl market.

Major companies in the fentanyl market are developing innovative products such as Opvee and securing approvals to reach larger customer bases, increase sales, and boost revenue. Opvee (nalmefene) is a potent opioid receptor blocker used to treat known or suspected opioid overdoses caused by natural or synthetic opioids, including fentanyl. For instance, in May 2023, Indivior PLC, a US-based pharmaceutical company, received U.S. Food and Drug Administration approval for Opvee nasal spray. The drug works by blocking the effects of opioids on the brain, helping patients who have recently overdosed restore normal respiration and blood pressure. Delivered as a nasal spray, Opvee is easy to administer in emergencies and is an essential addition to the range of medications used to combat opioid overdoses and save lives.

In April 2023, SK Capital Partners LP, a US-based private investment company, acquired Apotex Pharmaceutical Holdings Inc. for an undisclosed amount. The acquisition aims to expand Apotex's product portfolio, establish it as a Canadian global health firm, and leverage its expertise in low-cost medications. Apotex Pharmaceutical Holdings Inc. is a Canada-based pharmaceutical company that produces fentanyl transdermal systems.

Major companies operating in the fentanyl market are Pfizer Inc., Johnson & Johnson, Fresenius Kabi Oncology Ltd., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Hisamitsu Pharmaceutical Co. Inc., Alvogen, Insys Therapeutics Inc., Paladin Labs Inc., Apotex Inc., Kyowa Kirin Co. Ltd., Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Sinopharm Group, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, Validus Pharmaceuticals LLC, Quality Care Products LLC, Bryant Ranch Prepack Inc., Exela Pharma Sciences LLC

North America was the largest region in the fentanyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fentanyl market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fentanyl market consists of sales of fentanyl patch, fentanyl lozenge, fentanyl nasal spray, fentanyl sublingual spray, fentanyl sublingual tablets, fentanyl lollipop, and fentanyl film. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fentanyl Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses fentanyl market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fentanyl ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fentanyl market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Fentanyl Injections; Fentanyl TTS (Transdermal Therapeutic System)
• 2) By Application: Inducting Anesthesia; Maintain Anesthesia; General Analgesic; Postoperative Analgesia; Breakthrough Cancer Pain
• 3) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Fentanyl Injections: Injectable Solutions; Premixed Injection Formulations
• 2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations; Matrix Patch Systems
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Fresenius Kabi Oncology Ltd.; Viatris Inc.; Baxter International Inc.; Teva Pharmaceutical Industries Limited; Hisamitsu Pharmaceutical Co. Inc.; Alvogen; Insys Therapeutics Inc.; Paladin Labs Inc.; Apotex Inc.; Kyowa Kirin Co. Ltd.; Luye Pharma Group; Henan Lingrui Pharmaceutical Ltd.; Sinopharm Group; Jiangsu Nhwa Pharmaceutical Co. Ltd.; Cephalon LLC; Validus Pharmaceuticals LLC; Quality Care Products LLC; Bryant Ranch Prepack Inc.; Exela Pharma Sciences LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.